Royal London Asset Management Ltd. Acquires 7,381 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Royal London Asset Management Ltd. grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 8.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 96,106 shares of the medical instruments supplier’s stock after buying an additional 7,381 shares during the period. Royal London Asset Management Ltd.’s holdings in DENTSPLY SIRONA were worth $3,420,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of XRAY. VisionPoint Advisory Group LLC raised its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the period. Principal Securities Inc. bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Headlands Technologies LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $30,000. Parkside Financial Bank & Trust lifted its holdings in shares of DENTSPLY SIRONA by 33.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $47,000. 95.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Gregory T. Lucier acquired 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was bought at an average price of $27.95 per share, with a total value of $99,977.15. Following the acquisition, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

XRAY has been the topic of a number of recent research reports. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. SVB Leerink started coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. Finally, Piper Sandler restated a “neutral” rating and set a $32.00 price objective (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Moderate Buy” and a consensus target price of $35.22.

View Our Latest Stock Analysis on XRAY

DENTSPLY SIRONA Trading Down 0.3 %

NASDAQ XRAY opened at $27.69 on Monday. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -62.93, a PEG ratio of 1.24 and a beta of 1.04. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $41.65. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. The business’s fifty day moving average is $29.45 and its 200-day moving average is $32.36.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.39 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 2.02 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Investors of record on Friday, June 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.31%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.